Univariate Cox regression | Multivariate Cox regression | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.03 | 0.97–1.10 | 0.303 | |||
Female | 1.16 | 0.43–3.13 | 0.763 | |||
Body mass index | 1.08 | 0.94–1.24 | 0.288 | |||
AF duration | 1.01 | 1.00–1.02 | 0.172 | |||
Persistent AF | 2.37 | 0.54–10.45 | 0.254 | |||
CHA2DS2-VASc score | 1.28 | 0.97–1.68 | 0.085 | |||
Diabetes mellitus | 0.83 | 0.24–2.91 | 0.767 | |||
Hypertension | 1.30 | 0.48–3.49 | 0.609 | |||
Previous stroke or TIA | 2.16 | 0.78–5.94 | 0.137 | |||
Heart failure | 3.01 | 0.86–10.58 | 0.086 | 3.84 | 1.07–13.74 | 0.038 |
Coronary artery disease | 1.22 | 0.44–3.35 | 0.702 | |||
Chronic kidney disease | 2.65 | 0.60–11.78 | 0.199 | |||
LVEF | 0.99 | 0.94–1.04 | 0.718 | |||
LA diameter | 1.04 | 0.94–1.15 | 0.420 | |||
LVESD | 1.02 | 0.95–1.09 | 0.621 | |||
LVEDD | 1.02 | 0.95–1.10 | 0.606 | |||
Anticoagulants | 2.57 | 0.73–9.01 | 0.141 | |||
β-blockers | 1.92 | 0.54–6.77 | 0.313 | |||
Antiarrhythmics (Class I or III) | 1.06 | 0.30–3.75 | 0.923 | |||
Calcium channel blockers | 0.69 | 0.16–3.04 | 0.624 | |||
Digoxin | 1.03 | 0.33–3.18 | 0.966 | |||
Catheter ablation therapy | 0.30 | 0.10–0.93 | 0.037 | 0.27 | 0.09–0.84 | 0.024 |